← Back to Search

Video-Based Intervention for BRCA Gene Mutations

N/A
Waitlist Available
Led By Leigha Senter, LGC
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights

Study Summary

This trial is studying how effective a video-based intervention is in encouraging participants' families to get tested for BRCA gene mutations. The goal is to reduce the cancer burden by allowing for risk management and reduction.

Who is the study for?
This trial is for individuals who have tested positive for BRCA1 or BRCA2 gene mutations. It's designed to see if they can encourage their family members to get tested too, using a video-based intervention sent via text.Check my eligibility
What is being tested?
The study is testing the effectiveness of a video message intervention in motivating family members of participants with BRCA gene mutations to undergo genetic testing, potentially aiding in cancer prevention and risk management.See study design
What are the potential side effects?
Since this trial involves survey administration and an informational intervention rather than medication or medical procedures, there are no direct physical side effects expected from participation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Impact of a web-based video delivered via text message or shared on social media on information sharing among relatives belonging to families with BRCA gene mutations
Impact of participant-reported family dynamics on information sharing

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm A (video via text message)Experimental Treatment2 Interventions
Participants receive a 2-minute information-graphic video via text message consisting of misconceptions and issues that may be paramount when discussing mutation status with relatives that they can share with family via text message, email, or social media.
Group II: Arm B (letter via standard U.S. mail)Active Control2 Interventions
Participants receive family letter via U.S. postal service mail consisting of misconceptions and issues that may be paramount when discussing mutation status with relatives.

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
321 Previous Clinical Trials
289,920 Total Patients Enrolled
Leigha Senter, LGCPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Media Library

Video-Based Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05264532 — N/A
BRCA2 Mutation Research Study Groups: Arm A (video via text message), Arm B (letter via standard U.S. mail)
BRCA2 Mutation Clinical Trial 2023: Video-Based Intervention Highlights & Side Effects. Trial Name: NCT05264532 — N/A
Video-Based Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05264532 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age threshold for participation in this experiment limited to individuals 65 and older?

"The cutoff for age eligibility in this trial is 18 years old and the upper limit is 80."

Answered by AI

Is it possible for me to partake in this research endeavor?

"This medical trial is seeking 200 participants, aged between 18 and 80 years of age, who are confirmed to have a BRCA 1 mutation. In addition to this pre-requisite, eligible individuals must receive the video message/family letter which will be offered out to family members."

Answered by AI

Is there an ongoing recruitment process for this experiment?

"Absolutely, the information on clinicaltrials.gov confirms that recruitment is currently underway for this trial. It was first posted in April of 2018 and modified as recently as March 2022; it seeks to enrol 200 individuals at a single medical site."

Answered by AI

What is the total enrollment number for this medical experiment?

"Affirmative. Records hosted on clinicaltrials.gov validate this medical trial is actively enrolling patients, with the initial post being made on April 5th 2018 and last updated March 2nd 2022. The research team seeks 200 participants from 1 site for their study."

Answered by AI
~28 spots leftby May 2025